Sample results
Estrogen-dependent cancers are malignancies whose growth is stimulated by estrogen hormones, including certain breast, endometrial, and ovarian cancers. These cancers develop when cells with estrogen receptors grow abnormally in response to estradiol and other estrogen hormones. The Estradiol, Ultrasensitive, LC/MS/MS test is the most important test for assessing estrogen levels and hormone-related cancer risk.
Estrogen-dependent cancers are caused by prolonged exposure to estrogen hormones, particularly estradiol, which stimulates the growth of cells with estrogen receptors. Risk factors include early menstruation, late menopause, hormone replacement therapy, obesity (which increases estrogen production), and never having been pregnant. Genetic mutations like BRCA1 and BRCA2 also increase susceptibility to these hormone-sensitive cancers by affecting DNA repair mechanisms in estrogen-responsive tissues.
The Estradiol, Ultrasensitive, LC/MS/MS test is the most important test for assessing estrogen-dependent cancer risk because it measures estradiol, the most potent form of estrogen that directly stimulates estrogen receptor-positive cancer cells. This ultrasensitive method accurately detects even low levels of estradiol in the blood, making it essential for risk stratification in people with family history or other risk factors. While blood tests cannot diagnose cancer itself, monitoring estradiol levels helps identify individuals at higher risk who may benefit from enhanced screening, lifestyle modifications, or preventive hormone-blocking therapies.
You should get tested if you have a strong family history of breast, ovarian, or endometrial cancer, especially in first-degree relatives. Testing is also recommended if you are considering or currently using hormone replacement therapy, have known BRCA mutations, experienced early menstruation or late menopause, or have obesity or other conditions that may increase estrogen production. Regular monitoring is important for individuals on hormone-blocking medications to ensure treatment effectiveness and for postmenopausal women with unexplained symptoms that could indicate elevated estrogen levels.
What this means
Your estradiol level is below the optimal range, which may contribute to mood changes, low energy, irregular periods, or fertility challenges. In postmenopausal women, lower levels are expected, but in premenopausal women or men, this could indicate hormonal imbalance affecting overall well-being.
Recommended actions
Maintain a healthy weight through balanced nutrition and regular exercise
Include phytoestrogen-rich foods like flaxseeds, legumes, and whole soy products
Ensure adequate sleep (7-8 hours) and manage stress through meditation or yoga
Consider retesting in 2-3 months, ideally during days 3-5 of your cycle if menstruating
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: